Intervencionismo coronario percutáneo en pacientes con enfermedad del tronco coronario izquierdo o enfermedad multivaso

Abstract

Patients with multivessel coronary disease or left main coronary artery disease represent a highly complex minority within ischemic heart disease. However, there is ongoing controversy over the best treatment approach in these cases: whether to opt for coronary artery bypass grafting or percutaneous coronary intervention. Current recommendations from the latest 2018 clinical practice guidelines are based on studies from the past decade, and since then, technological advancements in percutaneous coronary intervention have achieved significant improvements, offering a better clinical prognosis today. This has led to an increase in the annual number of procedures performed and has even opened the door to treating patients who in the past were clear candidates for coronary artery bypass grafting.